Qlucore secures further EU funding for RNA-based cancer diagnostics
Over the course of the programme, the company plans to develop and launch regulated diagnostic products that comply with the European Union's In Vitro Diagnostic Regulation (IVDR) framework
Credit: H_ko/Shutterstock
The third grant payment supports the development of CE-marked diagnostic software for acute myeloid leukaemia and bladder cancer, with commercial rollout targeted across Europe.
Register for FREE to keep reading
Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with:
- Insights into HPC, AI, lab informatics & data
- Curated content for life sciences, engineering & academia
- Access to Breakthroughs: real-world computing success
- Free reports & panels, including the Lab Informatics Guide
- White Papers & software updates for smarter research
Sign up now
Already a member? Log in here
Your data is protected under our privacy policy.
